- All Drug Categories
- Home
- Anti-cancer Drugs
- Healthcare Products
- Medical Information
- Statement
Iqirvo, as a medication for treating specific liver diseases, requires attention to liver function monitoring, drug interactions, and medicatio...
Iqirvo, as a PPAR agonist drug, commonly has side effects including liver dysfunction, gastrointestinal reactions, and increased risk of infect...
Abrotinib is an oral JAK1 inhibitor primarily used for the treatment of moderate to severe atopic dermatitis. Long term use requires an evaluat...
Attention should be paid to infection risk monitoring, specific population contraindications, and drug interaction management when using Abroti...
The medication precautions for Ritlecitinib should pay attention to the monitoring of risks and adverse reactions in special populations. Drug ...
Ritlecitinib can be used for a long time in the treatment of alopecia areata, but its efficacy and safety need to be evaluated regularly. Its ...
Ritlecitinib is a novel kinase inhibitor primarily used for the treatment of autoimmune diseases such as alopecia areata. The following provide...
The medication of Ritlecitinib for special populations needs to be personalized according to pregnancy, lactation, reproductive potential, ch...
The use of Olaparib in special populations needs to be adjusted according to pregnancy, lactation, liver and kidney function, and other conditi...
Olaparib, as a PARP inhibitor, exerts anti-tumor effects by blocking the DNA repair pathway. Its drug interactions mainly involve CYP enzyme me...
